The Curtain Rises On DNAProtein Interactions
For the first time, scientists have watched proteins interact with long single-stranded DNA molecules in real time.The new method should yield insights into DNA replication and repair, the researchers say.
For the first time, scientists have watched proteins interact with long single-stranded DNA molecules in real time (Anal. Chem., DOI: 10.1021/ac302117z). The new method should yield insights into DNA replication and repair, the researchers say.
Until now, scientists could only watch proteins interacting with double-stranded DNA or very short single strands, says Eric Greene of Columbia University, who developed the new method. But, he says, “Basically anything to do with DNA metabolism or DNA repair involves single-stranded DNA intermediates.”
To find a way to monitor long single strands, Greene built upon a method his team devised six years ago, which visualizes proteins binding to double-stranded DNA (Langmuir, DOI: 10.1021/la051944a). They tethered fluorescent DNA molecules to lipids in a bilayer that coated the surface of a microfluidic sample chamber. When the researchers flowed buffer through the chamber, the DNA molecules diffused within the bilayer, eventually aligning along a nanofabricated barrier in the bilayer. The researchers added proteins to the chamber and observed their interactions with DNA in real time by noting changes in the DNA’s fluorescent signal. The team called the method “DNA curtains” because the hundreds of aligned DNA strands—visualized by total internal reflection fluorescence microscopy—reminded them of a window curtain.
But the technique didn’t work with single-stranded DNA, which is so flexible that it often folds upon itself into extensive secondary structures that preclude protein binding. Also, the intercalating fluorescent dyes that label double-stranded DNA can break single strands of DNA.
So Greene and his coworkers found a way to simultaneously unravel folded-up single-stranded DNA and fluorescently label it. The key was a protein called replication protein A (RPA), which binds single strands during DNA replication to prevent them from folding up. When the researchers added a fluorescently labeled version of the protein to a DNA-curtains assay, it coated single-stranded DNA molecules, helping extend the DNA and keep it accessible to proteins. Because RPA coats all single-stranded DNA in cells, the researchers say, the ubiquitous protein is unlikely to interfere with the binding of other proteins.
To test whether the assay could visualize interactions of single-stranded DNA with other proteins, the team injected fluorescently tagged Sgs1 protein into a flow cell containing RPA-bound DNA curtains. Sgs1 is a yeast helicase protein involved in DNA repair. Using fluorescence microscopy to visualize the labeled RPA and Sgs1 proteins, the researchers watched Sgs1 bind single-stranded DNA in real time.
Greene says that the new assay will allow researchers to probe when and where proteins bind single-stranded DNA, and how multiple proteins influence each other’s binding. “We can watch all of this stuff as it happens,” he says.
Maria Spies of the University of Iowa says, “The DNA curtains approach combines the benefits of single-molecule and bulk studies.” That’s because, she explains, researchers can use it to visualize hundreds of single-stranded DNA molecules at the same time. “I can’t wait to try this system in my lab,” she says.
Related News
-
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. -
News Amgen sues Samsung biologics unit over biosimilar for bone disease
Samsung Bioepis, the biologics unit of Samsung, has been issued a lawsuit brought forth by Amgen over proposed biosimilars of Amgen’s bone drugs Prolia and Xgeva. -
News CPHI Podcast Series: Why we need to consider women in clinical trials
The latest episode of the CPHI Podcast Series with Lucy Chard covers women's health, specifically women's representation in clinical trials, the associated bias, and the impacts on health for this population. -
News US FDA does not approve MDMA therapy for PTSD, requests more data
The MDMA-based therapeutic developed by Lykos Therapeutics, a California-based Public Benefit Corporation (PBC), has been reviewed and unapproved by the US FDA. The regulator has requested additional phase III trial data for further safety and efficacy... -
News Novartis and Viatris latest facing lawsuit over HeLa cell misuse
Global pharmaceutical companies Novartis and Viatris are the latest hit with a lawsuit claim pertaining to alleged misuse of the ‘HeLa’ cell line from the estate of woman whose cancerous tissue cells were taken without consent. -
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production. -
News Novel oral Type 1 diabetes drug gains US FDA IND designation
A University of Alabama at Birmingham startup has gained FDA clearance for Investigational New Drug clinical trials for an oral Type 1 diabetes drug, a milestone for diabetes treatment. -
News A Day in the Life of a Vice President in R&D & Engineering
In the Day in the Life of Series, we've already had the chance to get to know a range of people in various roles in the pharma industry. In the latest interview we get a glimpse into the R&D side of things from Jennifer Sorrells, Vice Presiden...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance